Hematologic malignancies: Selected abstracts and commentary

Keyphrases

• Antibody Therapy 33%
• Chronic Myeloid Leukemia 33%
• Clinical Development 33%
• Disease Detection 33%
• Disease Management 33%
• Hematological Malignancies 100%
• Lymphoid Malignancies 33%
• New Advances 33%
• Non-Hodgkin Lymphoma 33%
• Positron Emission Tomography Scan 33%
• Radioimmunoconjugate 33%
• Rationally Designed 33%
• STI571 33%
• Targeted Therapy 33%
• Therapeutic Monoclonal Antibody 33%
• Tyrosine Kinase Inhibitor 33%
• Unconjugated Antibody 33%

Medicine and Dentistry

• Antibody Therapy 33%
• Chronic Myelogenous Leukemia 33%
• Disease Management 33%
• Diseases 33%
• Excitement 33%
• Hematologic Malignancy 100%
• Lymphoma 33%
• Monoclonal Antibody 33%
• Non-Hodgkin Lymphoma 33%
• Positron Emission Tomography 33%
• Sexually Transmitted Infection 33%
• Targeted Therapy 33%
• Tyrosine-Kinase Inhibitor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Myeloid Leukemia 33%
• Diseases 66%
• Hematologic Malignancy 100%
• Lymphoma 33%
• Monoclonal Antibody 33%
• Nonhodgkin Lymphoma 33%
• Protein Tyrosine Kinase Inhibitor 33%